BioAtla, Inc. (BCAB) Insider Trading

BioAtla, Inc. (BCAB) has 3 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 2, 2026.

Filings
3
Purchases
0
$0
Sales
0
$0
Insiders
3

Most active BCAB insiders

SHORT JAY M PHD
Chief Executive Officer
0 bought · 0 sold · Sept. 2, 2026
$438
Sievers Eric
Chief Medical Officer
0 bought · 0 sold · Sept. 2, 2026
$226
Vasquez Christian
Chief Financial Officer
0 bought · 0 sold · Sept. 2, 2026
$120

Latest BCAB Form 4 filings

Date Insider Value Shares Stake Pre-planned Links
Sept. 2, 2026 filed Aug. 31, 2026 Sievers Eric Chief Medical Officer $226 134 −1% No
Sept. 2, 2026 filed Aug. 31, 2026 Vasquez Christian Chief Financial Officer $120 71 −1% No
Sept. 2, 2026 filed Aug. 31, 2026 SHORT JAY M PHD Chief Executive Officer $438 259 −0% No

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.

Get alerted when BCAB insiders trade

Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.

Start free